The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

BE FOREWARNED IF YOU ARE CHASING DIVIDENDS $TEVA $MYL $PRGO $RDY $ABX $MCK $CAH $ESRX

August 9, 2017

  Dividend-chasing is in vogue. Given low interest rates, many investors say they have no other choice. Such thinking leads to costly mistakes. It just badly hurt those who had bought shares of Teva Pharmaceutical Industries TEVA,  because of its high dividend yield. This isn’t just an issue for Teva investors, of course. There are many companies whose share price is being held up by dividend chasers. Take what happened in this case, however, as a reminder to review your portfolio and then sell those dividend-paying stocks where underlying businesses are deteriorating. In the case of Teva, the warning signs were

Read More »

WEEKLY MARKET DIGEST: PREPARE FOR POTENTIAL FRONT RUNNING OF SEPTEMBER IN AUGUST, GOLD SOLD $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO

August 5, 2017

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. STRONG JOBS REPORT, MUELLER IMPANELS GRAND JURY, GOLD SOLD August 4, 2017 This is what you need to know today. Strong Jobs Report Non-farm Private Payrolls

Read More »

A NEW IDEA ON UNITED THERAPEUTICS, BUYOUT RUMORS AT $200 $UTHR $GSK $GILD

August 4, 2017

This post was just published on ZYX Buy Change Alert. UTHR is a biotech company.  It closed at $127.92.  There are rumors that GSK and GILD are competing to buy the company at around $200.  Based on rumors the stock has moved up to $138 in the pre-market. Consider accumulating up to 25% of the full core position size on any dip in the zone of $126 to $135.52. Consider scaling in in the smallest tranche that your account will allow as the stock can trade in a very wide range.  Stop zone is $113 to $117.43. This is suitable only for aggressive

Read More »

APPLE’S STOCK COULD DOUBLE ON THE ‘MOTHER OF ALL ARTIFICIAL-INTELLIGENCE PROJECTS’ $AAPL $MU $AMD $NVDA $GOOG $FB $MSFT $CRUS $AVGO $QRVO $ADI

August 2, 2017

There are times when it pays to look years ahead when you’re an investor. That time is now for Apple AAPL.  Under one scenario, Apple’s stock could double. At first glance, such a possibility seems ridiculous given current Wall Street’s price targets on Apple. Isn’t Wall Street often behind the curve? When I made the call to aggressively buy Apple at $18.71 for the very long term, I suggested that the stock could go to $143. This call was made long before Apple became a popular stock. Many called it outrageous; some even canceled their subscriptions to The Arora Report.

Read More »

WHAT COULD PUSH STOCKS EVEN HIGHER? TRUMP’S LATEST IDEA $AAPL $GLD $SLV $DUST $SPY $YM_F $PFE $GOOG $FB $SHOP

August 2, 2017

In my 30-plus years in the markets, I can safely say that most popular analysis methods do not work well. Still, I can attest that a combination of forward-looking macro analysis combined with a review of earnings projections works most of the time. In plain English: Look for change. New fundamental and macro developments often leave the technicals of the market in the dust. And the new macro development is an aggressive timeline for tax reform by the Trump administration. This is a change from the prevailing wisdom. To fully understand the impact, let’s start with a chart. Chart Please

Read More »

PROTECT PROFITS ON LOWE’S BY RAISING STOPS $LOW $AMZN

August 1, 2017

This post was just published on ZYX Buy Change Alert. LOW is long from $72.26.  As of this writing it is trading at $77.52. Partial profits have previously been taken.  LOW was recently bought on a down spike on fears of AMZN. Protect profits by raising stops on the remaining position in the zone of $75.73 to $76.34.  The new target zone is $78.68 to $81. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE  30 day trial. Check

Read More »

BUYOUT PROBABILITY ON FLEXION THERAPEUTICS LESSENED, TAKE PROFITS AND EXIT $FLXN

August 1, 2017

This post was just published on ZYX Buy Change Alert.   125 of our portfolio companies have been bought out.  Long-time subscribers to The Arora Report have profited handsomely from buyouts. FLXN has been a buyout candidate.  However the probability of a buyout has lessened based on recent developments. FLXN is long from an average price of $18.75.  It is trading at $22.31 as of this writing. Consider taking profits and exiting in the zone of $22 to $24.38. A special note for subscribers to The Arora Report Market Blog and our free service Generate Wealth Investment Newsletter: a additional post was provided to paying

Read More »

WEEKLY MARKET DIGEST: MOMO CROWDS’ STOPS HUNTED AND DESTROYED, GOLD RUNS ON GDP $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO

July 29, 2017

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. MOMO CROWDS’ STOPS HUNTED AND DESTROYED, GOLD RUNS ON GDP July 28, 2017 This is what you need to know today. Momo  Crowds’ Stops Hunted And

Read More »

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

Skip to content